Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ja Min

Showing results (161-170 of 175) with videos related to

Pageof 18
Sort By:
Science (New York, N.Y.)|February 14, 2004
RETRACTED: Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocystWoo Suk Hwang, Young June Ryu, Jong Hyuk Park, et al.
Journal of Clinical Medicine|July 26, 2020
Optimizing Preparative Regimen for Umbilical Cord Blood Transplantation in Adult Acute Leukemia Patients: Acute Lymphoblastic Leukemia Requires Myeloablative Conditioning but Not Acute Myeloid LeukemiaJa Min Byun, Junshik Hong, Doyeun Oh, et al.
Nature Communications|March 30, 2024
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trialChanghee Park, Ho Sup Lee, Ka-Won Kang, et al.
Blood|June 12, 2026
Anbalcabtagene autoleucel (PD-1 and TIGIT knockdown CD19 CAR-T) for relapsed/refractory large B-cell lymphoma (CRC01-01)Won Seog Kim, Seok Jin Kim, Dok Hyun Yoon, et al.
Experimental & Molecular Medicine|May 8, 2026
Machine learning-based integration of transcriptome and digital pathology for predicting chemoresistance in muscle-invasive bladder cancerJinahn Jeong, Gowun Jeong, YongHwan Kim, et al.
Blood Research|November 21, 2021
Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in KoreaJun Ho Yi, Gyeong-Won Lee, Ji Hyun Lee, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 6, 2025
Real-World Comparison of Carfilzomib, Lenalidomide, and Dexamethasone Versus Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma: KMM2004 StudyDo Young Kim, Chang-Ki Min, Hyeon-Seok Eom, et al.
Haematologica|June 11, 2026
The prognostic factors and immune microenvironment of primary plasma cell leukemia: the KMMWP-2204 studyMihee Kim, Ho Cheol Jang, Jae-Sook Ahn, et al.
Cancers|February 5, 2020
Genomic Landscape of Young-Onset Bladder Cancer and Its Prognostic Implications on Adult Bladder CancerSun-Wha Im, Chang Ohk Sung, Kun Suk Kim, et al.
Cancers|February 13, 2026
Second Salvage Autologous Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Multiple Myeloma in the Era of Novel Agents: Results of the KMM2301 StudyJongheon Jung, Ji Hyun Lee, Sung-Hyun Kim, et al.
Pageof 18

Showing results (161-170 of 175) with videos related to

Sort By:
Pageof 18
Science (New York, N.Y.)|February 14, 2004
RETRACTED: Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocystWoo Suk Hwang, Young June Ryu, Jong Hyuk Park, et al.
Journal of Clinical Medicine|July 26, 2020
Optimizing Preparative Regimen for Umbilical Cord Blood Transplantation in Adult Acute Leukemia Patients: Acute Lymphoblastic Leukemia Requires Myeloablative Conditioning but Not Acute Myeloid LeukemiaJa Min Byun, Junshik Hong, Doyeun Oh, et al.
Nature Communications|March 30, 2024
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trialChanghee Park, Ho Sup Lee, Ka-Won Kang, et al.
Blood|June 12, 2026
Anbalcabtagene autoleucel (PD-1 and TIGIT knockdown CD19 CAR-T) for relapsed/refractory large B-cell lymphoma (CRC01-01)Won Seog Kim, Seok Jin Kim, Dok Hyun Yoon, et al.
Experimental & Molecular Medicine|May 8, 2026
Machine learning-based integration of transcriptome and digital pathology for predicting chemoresistance in muscle-invasive bladder cancerJinahn Jeong, Gowun Jeong, YongHwan Kim, et al.
Blood Research|November 21, 2021
Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in KoreaJun Ho Yi, Gyeong-Won Lee, Ji Hyun Lee, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 6, 2025
Real-World Comparison of Carfilzomib, Lenalidomide, and Dexamethasone Versus Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma: KMM2004 StudyDo Young Kim, Chang-Ki Min, Hyeon-Seok Eom, et al.
Haematologica|June 11, 2026
The prognostic factors and immune microenvironment of primary plasma cell leukemia: the KMMWP-2204 studyMihee Kim, Ho Cheol Jang, Jae-Sook Ahn, et al.
Cancers|February 5, 2020
Genomic Landscape of Young-Onset Bladder Cancer and Its Prognostic Implications on Adult Bladder CancerSun-Wha Im, Chang Ohk Sung, Kun Suk Kim, et al.
Cancers|February 13, 2026
Second Salvage Autologous Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Multiple Myeloma in the Era of Novel Agents: Results of the KMM2301 StudyJongheon Jung, Ji Hyun Lee, Sung-Hyun Kim, et al.
Pageof 18